Literature DB >> 16440126

Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.

Yi Chun Lin1, Te Li Chen, Huang Ling Ju, Huan Shen Chen, Fu Der Wang, Kwok Woon Yu, Chen Yi Liu.   

Abstract

BACKGROUND AND
PURPOSE: Enterobacter spp. have emerged as an important cause of nosocomial bacteremia. The purpose of this study was to delineate the clinical, laboratory and microbiologic features that may influence prognosis of Enterobacter cloacae and enable a stratification of those patients at high risk of mortality.
METHODS: This retrospective study reviewed 108 episodes of E. cloacae bacteremia occurring over a 2-year period (November 2001 to October 2003) at Taipei Veterans General Hospital. Univariate analysis were performed to demonstrate the relation of possible risk factors to death attributable to E. cloacae bacteremia.
RESULTS: Ninety-three episodes (86.1%) were hospital-acquired. The most common portal of entry was the genitourinary tract (17.9%) followed by the gastrointestinal tract (15.1%). Underlying diseases associated with E. cloacae bacteremia were neoplastic diseases (42 episodes, 38.9%), diabetes mellitus (20 episodes, 18.5%) and chronic renal failure (18 episodes, 16.7%). The overall mortality rate was 42.6%, and E. cloacae bacteremia-attributable mortality occurred in 22 patients (20.9%). Factors significantly correlated with death attributable to bacteremia were older age, a higher medium number of underlying diseases, hemoglobin <10 g/dL, serum C-reactive protein >10 mg/dL, hypoalbuminemia, disseminated intravascular coagulation, septic shock, respiratory failure, renal failure (creatinine >2 mg/dL) and delayed clinical response after initiation of antibiotic therapy.
CONCLUSIONS: Antibiotic-resistant isolates and appropriate empirical antibiotic use were not independent predictors of mortality in this study. The condition of patients at onset of symptoms and presence of underlying diseases appear to be important predictors mortality from E. cloacae bacteremia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440126

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  11 in total

1.  Characterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis.

Authors:  Jan K Hennigs; Hans Jörg Baumann; Stefan Schmiedel; Pierre Tennstedt; Ingo Sobottka; Carsten Bokemeyer; Stefan Kluge; Hans Klose
Journal:  Lung       Date:  2011-10-19       Impact factor: 2.584

2.  Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections.

Authors:  M Michalia; M Kompoti; A Koutsikou; A Paridou; P Giannopoulou; E Trikka-Graphakos; P Clouva-Molyvdas
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

3.  Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.

Authors:  Jason P Burnham; Michael A Lane; Marin H Kollef
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

Review 4.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

5.  Community-acquired bacteremia and acute cholecystitis due to Enterobacter cloacae: a case report.

Authors:  Guillermo Isasti; Laura Mora; Victoria García; Jesus Santos; Rosario Palacios
Journal:  J Med Case Rep       Date:  2009-09-11

6.  Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-2007.

Authors:  M N Al-Hasan; B D Lahr; J E Eckel-Passow; L M Baddour
Journal:  Clin Microbiol Infect       Date:  2011-04       Impact factor: 8.067

7.  Enterobacter cloacae: an "ICU bug" causing community acquired necrotizing meningo-encephalitis.

Authors:  Nitin Maheshwari; Alison Shefler
Journal:  Eur J Pediatr       Date:  2008-07-26       Impact factor: 3.183

Review 8.  New treatment options against gram-negative organisms.

Authors:  Matteo Bassetti; Francesca Ginocchio; Malgorzata Mikulska
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

9.  Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.

Authors:  Vikas P Chaubey; Johann D D Pitout; Bruce Dalton; Daniel B Gregson; Terry Ross; Kevin B Laupland
Journal:  BMC Infect Dis       Date:  2014-12-14       Impact factor: 3.090

10.  Transmission of Enterobacter aerogenes septicemia in healthcare workers.

Authors:  Piyush Jha; Choon-Mee Kim; Dong-Min Kim; Jong-Hoon Chung; Na-Ra Yoon; Babita Jha; Seok Won Kim; Sook Jin Jang; Young-Joon Ahn; Jae Keun Chung; Doo Young Jeon
Journal:  Springerplus       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.